Major histocompatibility complex class II molecule expression on muscle cells is regulated by differentiation: Implications for the immunopathogenesis of muscle autoimmune diseases

Renato Mantegazza, Marinella Gebbia, Marina Mora, Rita Barresi, Pia Bernasconi, Fulvio Baggi, Ferdinando Cornelio

Research output: Contribution to journalArticle

Abstract

Major histocompatibility complex (MHC) class II molecules are expressed on myoblasts after interferon-γ (IFN-γ) treatment, suggesting a muscle cell involvement in antigen presentation in inflammatory myopathies. However, they were not observed on normal or pathological myofibers. This discrepancy might be related to different responsiveness of developmentally differentiated muscle cells to IFN-γ. Myoblasts expressed class II transcripts and proteins after IFN-γ, while myotubes and innervated contracting muscle cells did not show staining for class II molecules. At all cell stages no loss of IFN-γ receptor was detected indicating-that myofiber maturation blocks their capacity to express MHC class II molecules. This suggests that completely differentiated myofibers cannot participate in class II restricted immunological reactions.

Original languageEnglish
Pages (from-to)53-60
Number of pages8
JournalJournal of Neuroimmunology
Volume68
Issue number1-2
DOIs
Publication statusPublished - Aug 1996

Fingerprint

Major Histocompatibility Complex
Muscle Cells
Interferons
Autoimmune Diseases
Myoblasts
Muscles
Interferon Receptors
Myositis
Skeletal Muscle Fibers
Antigen Presentation
Staining and Labeling
Proteins

Keywords

  • Autoimmunity
  • Interferon-
  • Major histocompatibility complex
  • Muscle cell

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

@article{8d18d39ba6b4404fb080746add307909,
title = "Major histocompatibility complex class II molecule expression on muscle cells is regulated by differentiation: Implications for the immunopathogenesis of muscle autoimmune diseases",
abstract = "Major histocompatibility complex (MHC) class II molecules are expressed on myoblasts after interferon-γ (IFN-γ) treatment, suggesting a muscle cell involvement in antigen presentation in inflammatory myopathies. However, they were not observed on normal or pathological myofibers. This discrepancy might be related to different responsiveness of developmentally differentiated muscle cells to IFN-γ. Myoblasts expressed class II transcripts and proteins after IFN-γ, while myotubes and innervated contracting muscle cells did not show staining for class II molecules. At all cell stages no loss of IFN-γ receptor was detected indicating-that myofiber maturation blocks their capacity to express MHC class II molecules. This suggests that completely differentiated myofibers cannot participate in class II restricted immunological reactions.",
keywords = "Autoimmunity, Interferon-, Major histocompatibility complex, Muscle cell",
author = "Renato Mantegazza and Marinella Gebbia and Marina Mora and Rita Barresi and Pia Bernasconi and Fulvio Baggi and Ferdinando Cornelio",
year = "1996",
month = "8",
doi = "10.1016/0165-5728(96)00068-9",
language = "English",
volume = "68",
pages = "53--60",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier Science B.V.",
number = "1-2",

}

TY - JOUR

T1 - Major histocompatibility complex class II molecule expression on muscle cells is regulated by differentiation

T2 - Implications for the immunopathogenesis of muscle autoimmune diseases

AU - Mantegazza, Renato

AU - Gebbia, Marinella

AU - Mora, Marina

AU - Barresi, Rita

AU - Bernasconi, Pia

AU - Baggi, Fulvio

AU - Cornelio, Ferdinando

PY - 1996/8

Y1 - 1996/8

N2 - Major histocompatibility complex (MHC) class II molecules are expressed on myoblasts after interferon-γ (IFN-γ) treatment, suggesting a muscle cell involvement in antigen presentation in inflammatory myopathies. However, they were not observed on normal or pathological myofibers. This discrepancy might be related to different responsiveness of developmentally differentiated muscle cells to IFN-γ. Myoblasts expressed class II transcripts and proteins after IFN-γ, while myotubes and innervated contracting muscle cells did not show staining for class II molecules. At all cell stages no loss of IFN-γ receptor was detected indicating-that myofiber maturation blocks their capacity to express MHC class II molecules. This suggests that completely differentiated myofibers cannot participate in class II restricted immunological reactions.

AB - Major histocompatibility complex (MHC) class II molecules are expressed on myoblasts after interferon-γ (IFN-γ) treatment, suggesting a muscle cell involvement in antigen presentation in inflammatory myopathies. However, they were not observed on normal or pathological myofibers. This discrepancy might be related to different responsiveness of developmentally differentiated muscle cells to IFN-γ. Myoblasts expressed class II transcripts and proteins after IFN-γ, while myotubes and innervated contracting muscle cells did not show staining for class II molecules. At all cell stages no loss of IFN-γ receptor was detected indicating-that myofiber maturation blocks their capacity to express MHC class II molecules. This suggests that completely differentiated myofibers cannot participate in class II restricted immunological reactions.

KW - Autoimmunity

KW - Interferon-

KW - Major histocompatibility complex

KW - Muscle cell

UR - http://www.scopus.com/inward/record.url?scp=0030219707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030219707&partnerID=8YFLogxK

U2 - 10.1016/0165-5728(96)00068-9

DO - 10.1016/0165-5728(96)00068-9

M3 - Article

C2 - 8784260

AN - SCOPUS:0030219707

VL - 68

SP - 53

EP - 60

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -